Equity Profile
Post-Earnings Recap
AXSOME THERAPEUTICS
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.32 | $0.26 | +19.85% |
| Revenue | — | $3.8B | — |
management commentary, guidance changes, and full analysis available with Pro.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
Kenvue Inc. is a leading company in the consumer staples sector, focusing on personal care products....
EPS
Earnings per share (EPS) is a key indicator of profitability and is closely watched by investors.
Revenue
Total revenue reflects the company's sales performance and market demand for its products.
Wall Street expectations, options signals, track record, and call prep available with Pro.
Mixed
1 trade
Net selling
Recent Transactions
Traded Mar 17, 2026 · disclosed Apr 3, 2026
$15,001.00–$50,000.00
Traded Mar 13, 2026 · disclosed Apr 7, 2026
$1,001.00–$15,000.00
Traded Feb 10, 2026 · disclosed Mar 9, 2026
$1,001.00–$15,000.00
Traded Jan 9, 2026 · disclosed Feb 13, 2026
$1,001.00–$15,000.00
Filed 30–45+ days after the trade. Treat as positional context, not a leading indicator. Amounts are SEC-mandated dollar ranges, not exact values.